Imunon, Inc. Operating Lease Right-of-Use Assets
Imunon, Inc. (IMNN) had Operating Lease Right-of-Use Assets of $788.89 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-11
- 2026-06-30: Operating Lease, Right-of-Use Asset $788.89K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $887.89K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $984.44K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $1.08M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $788.89K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $887.89K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $984.44K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $1.08M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.17M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $985.89K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.12M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.25M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.37M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $1.49M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $1.60M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.66M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $1.29M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $155.88K 10-K · filed 2024-03-28 |
| 2022-09-30 | $294.81K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $430.41K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $562.38K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $691.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $816.52K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $840.20K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $945.07K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.05M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.15M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.24M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $1.34M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $1.43M 10-K · filed 2021-03-19 |
| 2019-09-30 | $1.52M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.61M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $1.70M 10-Q · filed 2019-05-15 |
| 2019-01-02 | $400.00K 10-K · filed 2022-03-31 |
| 2018-12-31 | $1.10M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |